Antibiotic use reduces efficacy of tyrosine kinase inhibitors in patients with advanced melanoma and non-small-cell lung cancer

BACKGROUND: Antibiotic (ABX) use can reduce the efficacy of immune checkpoint inhibitors and chemotherapeutics. The effect for patients treated with targeted therapies, namely, small-molecule tyrosine kinase inhibitors (TKIs), is less known. PATIENTS AND METHODS: Retrospective data were analysed for...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinsley, N., Zhou, C., Nahm, S., Rack, S., Tan, G.C.L., Lorigan, P., Blackhall, F., Cook, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271482/
https://www.ncbi.nlm.nih.gov/pubmed/35489288
http://dx.doi.org/10.1016/j.esmoop.2022.100430

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271482/
https://www.ncbi.nlm.nih.gov/pubmed/35489288
http://dx.doi.org/10.1016/j.esmoop.2022.100430

Ejemplares similares